Filing Details
- Accession Number:
- 0001562180-25-000246
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-07 16:42:25
- Reporting Period:
- 2025-01-03
- Accepted Time:
- 2025-01-07 16:42:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1860782 | 2Seventy Bio Inc. | TSVT | Pharmaceutical Preparations (2834) | 863658454 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2009134 | Jessica Snow | 60 Binney Street Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-03 | 1,000 | $2.94 | 152,479 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-06 | 114 | $2.78 | 152,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-06 | 5,000 | $2.79 | 147,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-07 | 186 | $2.64 | 147,179 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.76 to $2.785, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.63 to $2.95, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
